Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.
about
The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapyThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityMitochondrial DNA depletion and fatal infantile hepatic failure due to mutations in the mitochondrial polymerase γ (POLG) gene: a combined morphological/enzyme histochemical and immunocytochemical/biochemical and molecular genetic studyIn vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration.Tenofovir renal toxicity targets mitochondria of renal proximal tubules.Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.Tenofovir-associated bone density loss.Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitorsGenome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.Aging and HIV/AIDS: pathogenetic role of therapeutic side effectsHuman immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cordsEuropean mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma - method-comparison evaluationsMechanisms of zidovudine-induced mitochondrial toxicity and myopathy.Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.Protective effect of calycosin-7-O-β-D-glucopyranoside against oxidative stress of BRL-3A cells induced by thioacetamide.Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option?A novel mechanism of selectivity against AZT by the human mitochondrial DNA polymerase.A brief overview of mechanisms of mitochondrial toxicity from NRTIs.Lamivudine-Induced Liver Injury.Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathyPharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathyMitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapyCoconut Oil Extract Mitigates Testicular Injury Following Adjuvant Treatment with Antiretroviral Drugs.High frequency of mitochondrial DNA mutations in HIV-infected treatment-experienced individuals.Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.Central role of mitochondria in drug-induced liver injury.Fidelity of the human mitochondrial DNA polymerase.Cardiomyocytes are Protected from Antiretroviral Nucleoside Analog-Induced Mitochondrial Toxicity by Overexpression of PGC-1α.Mitochondrial purine and pyrimidine metabolism and beyond.Pro-oxidant properties of AZT and other thymidine analogues in macrophages: implication of the azido moiety in oxidative stress.Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanismMitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs.Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementiaAZT-induced oxidative cardiovascular toxicity: attenuation by Mg-supplementation.
P2860
Q27027887-0EF2DC36-B4CB-4CB4-A197-DE880B433A11Q28080256-9791D8AD-993B-43B5-A906-F3C1300391A6Q30447289-6343A02F-B2B7-4D69-9C1D-3A925B383E29Q30885827-C37BD4E0-2526-4D56-8F74-DAAB70FF7F24Q33416391-D26382D9-4833-4915-BD13-1D7AEF66B71EQ33551302-0837243B-E1D4-403F-99D1-676CF3163868Q33635034-FE8CF7F2-4DB6-41ED-B68D-8E0C8C8E81B6Q33904479-BF948092-01EE-4379-929B-9CF7DE6C4F43Q33967087-9957A2A7-F358-4581-A13D-DFF690746299Q34089694-E1E44F7E-1575-4A8C-8013-79C200DCAE12Q34196934-9ACAC2DA-744C-4678-AFC8-5EE94DB82C8CQ34358732-26FEF9D8-49F0-4A68-A46F-4F0702C5771DQ34372631-0B41003F-ADF7-4F9A-A2B9-254D5380E6E5Q34611901-CA31FF13-E03C-403F-B7F4-90039C3D8A42Q34657368-37A1F7DE-31ED-4FF5-B214-F1CBD7B71192Q34781865-B00E2B53-5826-45CE-ABE4-1C21D0EB6D4AQ35606742-5061C138-1CF6-4C75-AE2E-EE2F1A5BE831Q35738557-0472738C-F002-484A-8C80-4FE4A33AE417Q35910327-3BD122E2-D295-43EC-AF53-15FDC32A0FB4Q36255314-A1E47B4B-96BC-47AC-9443-BBD62F774F81Q36328820-F681C7CF-321B-4BB0-950C-E7765DD87E27Q36499104-768BE1AB-44DB-48FC-88D3-8C148955202FQ36929406-68AFFFF6-658F-4199-B4BD-2EBD418B1EB8Q36980757-C498E5D8-C1A7-4345-B831-A6EDB223525CQ37149019-EB824C80-2360-4FD6-84E9-43887AA45BCEQ37239515-048CE1FD-6401-454D-8FDD-006686CA6730Q37251569-99A6FD1F-175A-4B66-89F7-86D529C85232Q37344333-8977158C-29EA-414C-9A23-E72ADA4A3B8BQ37367561-A978BB80-BAFE-47D1-AFDF-7F61887A13B5Q37462154-AABF509B-3C09-4781-A928-609BB38052B3Q37798546-59599DF0-DC20-4494-B0EB-D810A1A69EEAQ37926590-0D431128-F498-4965-8E8D-6D3F294E4D45Q38309164-04DC3607-9F58-4BF5-BBA7-689AFA03224BQ38942113-E83FB089-471C-4067-9737-39405E88D8F2Q39025697-84D7A6AB-7C09-4F3B-BBF0-F0C9706F1C61Q39753791-3314AE99-076C-4986-BE07-8EF7836BFFE7Q39921380-A11FE6D4-7406-4339-B364-DBDA800F5037Q41293914-CD1D53AF-3C4D-4B0E-9955-2F49FB9D7F04Q41862645-84451280-6519-4FDB-924C-0ABB57E46CA1Q42454619-7B467A0B-C153-4B60-9D2E-744432F5849E
P2860
Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@ast
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@en
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@nl
type
label
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@ast
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@en
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@nl
prefLabel
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@ast
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@en
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@nl
P2093
P2860
P1476
Mitochondrial dna depletion, o ...... erse transcriptase inhibitors.
@en
P2093
P2860
P2888
P304
P356
10.1038/LABINVEST.3780288
P577
2001-06-01T00:00:00Z
P5875
P6179
1024658209